Thromboembolic prophylaxis in post-partum patients. Cross-sectional study in three institutions in Colombia
DOI:
https://doi.org/10.18597/rcog.364Keywords:
Venous thromboembolism, embolism and thrombosis, post-partum period, prevention and controlAbstract
Objective: To describe the risk of thromboembolic disease in post-partum patients and examine the current use of thromboprophylaxis.
Materials and methods: Descriptive cross-sectional study that included patients admitted for delivery care between August 2012 and April 2013 in three high-complexity general healthcare institutions in Bogotá and Medellín. The Royal College of Obstetrics & Gynaecology (RCOG) Management Guideline was applied for determining the risk of thromboembolic disease. Patients were assessed during the post-partum period and classified as high, intermediate and low risk. The actual frequency of the use of prophylaxis was measured. Results are presented as proportions.
Results: Overall, 3516 patients were assessed and 1.9 % were classified as high risk, 42 % as intermediate risk and 56.1 % as low risk. Thromboprophylaxis was only used in 7.4 % of patients with high or intermediate risk.
Conclusion: According to the criteria of the RCOG guidelines, 43.9 % of the patients had an indication for thromboprophylaxis and yet only 7.4 % of them received it. Further studies are required to assess the risk and evaluate the benefits and risks of giving thromboprophylaxis in accordance with the United Kingdom guidelines.
Author Biographies
Jaime Luis Silva-Herrera
Marco Antonio Duque-Giraldo
Camilo Torres-Chaparro
José Enrique Sanín-Blair
Magda Lizeth Niño-Peña
Ana María Higuita-Rendón
References
Departamento Nacional de Estadística (DANE). Estadísticas vitales. Muertes no fetales. Defunciones maternas por grupo de edad y causa [visitado 2016 Ene 21]. Disponible en: http://www.dane.gov.co/index.php/esp/poblacion-y-demografia/nacimientos-y-defunciones/118-demograficas/estadisticasvitales/4675-defunciones-no-fetales-2013.
Donnelly JC, D’Alton ME. Pulmonary embolus in pregnancy. Semin Perinatol. 2013;37:225-33.
Royal College of Obstetricians and Gynaecologists. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. Clinical Guideline. Green-top Guideline 28. London: RCOG; 2009.
James AH, Grotegut CA, Brancazio LR, Brown H. Thrombomebolism in pregnancy: recurrence and its prevention. Semin Perinatol. 2007;3:167-75.
The American College of Obstetrics and Gynecologist. Thromboembolism and Pregnancy. Practice Bulletin; 2011. p. 123.
SOGC Clinical Practice Guideline. Venous Thromboembolism and anti-thrombotic therapy in pregnancy. JOCG. 2014;308.
Kourlaba G, Relakis J, Kontodimas S, Holm MV, Maniadakis N. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet. 2016;132:4-10.
Rodger M. Pregnancy and venous thromboembolism: ‘TIPPS’ for risk stratification. Hematology Am Soc Hematol Educ Program. 2014;2014:387-92.
Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green Top Guideline No. 37; 2015.
Durán-Mendicutti A, Sodickson A. Imaging evaluation of the pregnant patient with suspected pulmonary embolism. Int J Obstet Anesth. 2011;20:51-9.
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e691S-736S.
Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006-08. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1-203.
Fundación Santafé de Bogotá. Centro de Innovación e investigación en salud. Zona libre de trombosis [visitado 2016 Feb 12]. Disponible en: https://www.zonalibredetrombosis.org/
Cregan A, Higgins JR, O’Shea S. Implementation of thromboprophylaxis guidelines. Ir Med J. 2013; 106:80-2.
Caiafa JS, de Bastos M, Moura LK, Raymundo S. Brazilian Registr y of venous thromboembolism prophylaxis. Managing venous thromboembolism in Latin American patients: emerging results from the Brazilian Registry. Semin Thromb Hemost. 2002;28 Suppl 3:47-50.
Friedman AM, Ananth CV, Prendergast E, Chauhan SP, D’Alton ME, Wright JD. Thromboembolism incidence and Prophylaxis during vaginal delivery hospitalizations. Am J Obstet Gynecol. 2015;212:221.e1-12.
Okoroh EM, Azonobi IC, Grosse SD, Grant AM, Atrash HK, James AH. Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011. J Womens Health (Larchmt). 2012;21:611-5.
Palmerola K, D’alton M. A comparison of recommendations for pharmacologic thromembolism prophylaxis after cesarean delivery from three major guidelines. BJOG.2015; DOI: 10.1111/1471-0528.13706.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
